Revance Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $6.9M | 602k | 11.47 |
| 2023-06-30 | $16M | 640k | 25.31 |
| 2022-12-31 | $15M | 799k | 18.46 |
| 2022-06-30 | $7.0M | 503k | 13.82 |
| 2022-03-31 | $0 | 417k | 0.00 |
| 2021-06-30 | $0 | 291k | 0.00 |
| 2020-12-31 | $0 | 152k | 0.00 |
| 2020-09-30 | $0 | 89k | 0.00 |
| 2020-06-30 | $0 | 99k | 0.00 |
| 2020-03-31 | $469k | 32k | 14.81 |
| 2019-12-31 | $1.5M | 90k | 16.23 |
| 2019-09-30 | $362k | 28k | 13.00 |
| 2019-03-31 | $1.7M | 108k | 15.75 |
| 2018-12-31 | $3.1M | 153k | 20.12 |
| 2018-09-30 | $3.8M | 154k | 24.85 |
| 2018-06-30 | $5.0M | 183k | 27.45 |
| 2018-03-31 | $5.2M | 170k | 30.80 |
| 2017-12-31 | $8.2M | 228k | 35.75 |
| 2017-03-31 | $3.2M | 154k | 20.79 |
| 2016-12-31 | $3.8M | 181k | 20.70 |
| 2016-09-30 | $2.1M | 116k | 17.86 |
| 2016-06-30 | $1.2M | 90k | 13.81 |
| 2016-03-31 | $1.3M | 75k | 17.39 |
| 2015-12-31 | $702k | 21k | 33.77 |
| 2015-09-30 | $119k | 3.6k | 33.33 |
| 2015-06-30 | $1.9M | 59k | 31.94 |
| 2014-12-31 | $111k | 6.5k | 16.99 |
| 2014-09-30 | $115k | 5.9k | 19.43 |
| 2014-06-30 | $153k | 4.5k | 33.99 |
| 2014-03-31 | $2.3M | 63k | 36.36 |